Boston Scientific accounts are for healthcare professionals only.
Our priorities
2023 highlights
82%
renewable electricity1,2
72%
real estate independently certified for energy efficiency3
77%
of solid, non-hazardous waste recycled1
1 Inclusive of all manufacturing and key distribution sites only.
2 Includes renewable electricity generated onsite and purchased electricity matched with electricity from renewable sources.
3 Percentage of all Boston Scientific real estate (including commercial, leased and owned) that is independently certified for energy efficiency by industry-leading bodies such as LEED for design and Energy Star or ISO 50001:2018 for building operations.
Stories of impact
Our path to net zero
In 2022, Boston Scientific was first in the Healthcare Equipment and Supplies sector to gain approval from Science Based Targets initiative (SBTi) for our target of net-zero greenhouse gas (GHG) emissions by 2050. We focus on making measurable, meaningful advances and will continue to report on our progress . Our SBTi-approved targets for net-zero GHG emissions encompass scopes 1, 2 and 3. Read more about our approach to emissions reduction.
Key environmental sustainability initiatives
As of July 29, 2022, the Science Based Targets initiative (SBTi) approved the Boston Scientific science-based net-zero target and near- and long-term emission reduction targets:
Overall Net-Zero Target
Boston Scientific Corporation commits to reach net-zero greenhouse gas emissions across the value chain by 2050 from a 2019 base year.
Near-Term Targets
Multinational U.S. healthcare and equipment supplies company Boston Scientific Corporation commits to reduce absolute Scope 1 & 2 GHG emissions 46.2% by 2030 from a 2019 base year. Boston Scientific Corporation also commits to reduce Scope 3 GHG emissions from Purchased Goods & Services, Capital Goods, Fuel & Energy-Related Activities, Upstream transportation & Distribution, and Business travel GHG emissions 55% per USD value added within the same timeframe.
Long-Term Targets
Boston Scientific Corporation commits to reduce Scope 1 and 2 GHG emissions 97% per USD value added, equivalent to 90% absolute reduction, by 2050 from a 2019 base year. Boston Scientific Corporation also commits to reduce Scope 3 GHG emissions 97% per USD value added within the same timeframe.
In 2017, we became one of the first medical device manufacturers to pledge to achieve carbon neutrality by 2030 in all of our manufacturing and key distribution sites. This steady progress has been driven by our Global Energy Management System and our C3 strategy, which guides priorities and programs in the following areas:
- Cut energy use – by investing in energy efficiency at our existing sites and new construction that meets the highest climate standards.
- Convert – to renewable energy sources companywide instead of relying on fossil fuels.
- Compensate – with carbon credits and offset projects for remaining unavoidable emissions.
Our Global Packaging and Labeling Sustainability team uses data to evaluate sustainable packaging materials, guide and quantify packaging sustainability improvements and support sustainable suppliers.
Our Global Packaging and Labeling Sustainability strategy focuses on:
- Reducing the amount of material in packaging
- Redesigning packaging for sustainability and supply chain efficiency
- Improving recyclability of all packaging and using recycled content where possible
- Responsibly sourcing packaging materials in collaboration with suppliers
- Monitoring regulatory developments and advocating for sustainable packaging requirements
We have set a goal to reduce our scope 3 GHG emissions by 55% per U.S. dollar (USD) value added by 20301. Collaborating with suppliers across our global supply chain is key to understanding and implementing sustainability initiatives that can have the most impact across our global supply chain.
We approach supplier engagement with a focus on the following:
- Identify top 80% of suppliers by emissions
- Share sustainability best practices and assist in setting and reporting progress on targets
- Pursue abatement/reduction levers, including renewable energy, discussion of hotspot opportunities
1 Boston Scientific has a goal to reduce scope 3 GHG emissions intensity from Purchased Goods & Services, Capital Goods, Fuel & Energy-Related Activities, Upstream Transportation & Distribution, and Business Travel by 55% per USD value added by 2030 from a 2019 base year. Our GHG emissions intensity is calculated as units of carbon equivalent emitted per unit of gross profit.
Our end-to-end ideal product flow initiative is focused on driving more efficiency and sustainability in how our products are sourced, manufactured, packaged and distributed. This focus strengthens the efficiency of our value chain, reducing our freight carbon impact by several thousand tons annually.
